Northern Trust’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-65,334
| Closed | -$5.66K | – | 4615 |
|
|
2023
Q3 | $5.66K | Sell |
65,334
-7,565
| -10% | -$2.18K | ﹤0.01% | 4430 |
|
|
2023
Q2 | $40.8K | Hold |
72,899
| – | – | ﹤0.01% | 4266 |
|
|
2023
Q1 | $83.1K | Hold |
72,899
| – | – | ﹤0.01% | 4123 |
|
|
2022
Q4 | $81.6K | Buy |
72,899
+8,427
| +13% | +$13.4K | ﹤0.01% | 4160 |
|
|
2022
Q3 | $135K | Sell |
64,472
-6,619
| -9% | -$12.9K | ﹤0.01% | 4020 |
|
|
2022
Q2 | $97K | Sell |
71,091
-3,860
| -5% | -$5.59K | ﹤0.01% | 4184 |
|
|
2022
Q1 | $127K | Buy |
74,951
+29,561
| +65% | +$42.3K | ﹤0.01% | 4279 |
|
|
2021
Q4 | $49K | Buy |
45,390
+19,233
| +74% | +$31.2K | ﹤0.01% | 4598 |
|
|
2021
Q3 | $77K | Hold |
26,157
| – | – | ﹤0.01% | 4462 |
|
|
2021
Q2 | $79K | Sell |
26,157
-118,377
| -82% | -$362K | ﹤0.01% | 4415 |
|
|
2021
Q1 | $472K | Sell |
144,534
-16,371
| -10% | -$67.3K | ﹤0.01% | 3829 |
|
|
2020
Q4 | $663K | Sell |
160,905
-1,824
| -1% | -$10.5K | ﹤0.01% | 3646 |
|
|
2020
Q3 | $881K | Buy |
162,729
+69,389
| +74% | +$400K | ﹤0.01% | 3443 |
|
|
2020
Q2 | $628K | Sell |
93,340
-36,378
| -28% | -$178K | ﹤0.01% | 3494 |
|
|
2020
Q1 | $413K | Buy |
129,718
+30,552
| +31% | +$163K | ﹤0.01% | 3503 |
|
|
2019
Q4 | $693K | Buy |
99,166
+11,357
| +13% | +$60.6K | ﹤0.01% | 3496 |
|
|
2019
Q3 | $337K | Sell |
87,809
-11,640
| -12% | -$39.4K | ﹤0.01% | 3635 |
|
|
2019
Q2 | $378K | Buy |
99,449
+5,230
| +6% | +$17.4K | ﹤0.01% | 3633 |
|
|
2019
Q1 | $340K | Buy |
94,219
+14,757
| +19% | +$109K | ﹤0.01% | 3634 |
|
|
2018
Q4 | $615K | Buy |
+79,462
| New | +$636K | ﹤0.01% | 3508 |
|
Other funds holding RVLP
Northern Trust's RVLP Position: Q4 2023 in Review
Northern Trust sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 65,334 shares — an estimated $5.66K sold.
Northern Trust first reported a position in RVLP in Q4 2018 and held it in 20 quarters. The position peaked at $881K in Q3 2020. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.
- Northern Trust reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Northern Trust sold 65,334 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $5.66K.
- Northern Trust first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 20 quarters.
- Northern Trust's RVL Pharmaceuticals plc Ordinary Shares position peaked at $881K in Q3 2020.
- 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.
Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.